Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
ID | DOID:2156 |
Name | ovarian germ cell cancer |
Definition | An ovarian cancer that originates in the germ (egg) cells of the ovary. |
Source | DiseaseOntology.org |
Alt Ids | |
Path | disease disease of cellular proliferation cancer organ system cancer reproductive organ cancer female reproductive organ cancer ovarian cancer ovarian germ cell cancer |
Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
---|---|---|---|---|
MLH1 negative | Pembrolizumab | ovarian germ cell cancer | sensitive | detail... |
MSH6 negative | Pembrolizumab | ovarian germ cell cancer | sensitive | detail... |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02834013 | Phase 0 | Ipilimumab + Nivolumab | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | Active, not recruiting | USA | 1 |
NCT04876456 | Phase II | Cabozantinib | A Phase II Trial Evaluating the Efficacy of Cabozantinib With Patients With Refractory GCTs | Recruiting | USA | 0 |